申请人:Koenig Marcel
公开号:US20060009493A1
公开(公告)日:2006-01-12
The present invention relates to compounds of the formulae (I)-(XII), wherein R
1
-R
71
, A, B, X, Y, G, L and Z are defined herein, and their pharmaceutically acceptable salts. These compounds modulate the activity of c-Met and are therefore expected to be useful in the prevention and treatment of c-Met related disorders such as cancer.
本发明涉及式(I)-(XII)的化合物,其中R1-R71、A、B、X、Y、G、L和Z在此定义,并且它们的药学上可接受的盐。这些化合物调节c-Met的活性,因此预计在预防和治疗与c-Met相关的疾病,如癌症方面有用。